CXCL13 levels are more increased in cerebrospinal fluid and plasma of patients with acute infectious than in non-infectious diseases of the central nervous system
Open Access
- 18 February 2017
- journal article
- Published by Walter de Gruyter GmbH in Revista Romana de Medicina de Laborator
- Vol. 25 (1) , 63-73
Abstract
Background: During the acute inflammatory process, the CXCL13 chemokine plays an important role in B cell recruitment within the central nervous system (CNS). Objective: The objective of the study consisted of the evaluation of CXCL13 chemokine cerebral spinal fluid (CSF) and plasma levels in patients with acute infectious and non-infectious neurological diseases correlated with pleocytosis and CSF protein levels. Material and method: This retrospective study was conducted over one year and included 72 patients. Thirty-eight patients (52.8%) suffering from infectious neurological disease, acute viral and bacterial meningitis, meningoencephalitis, and 34 patients (44.2%) diagnosed with non-infectious neurological diseases. CXCL13 chemokine CSF and plasma levels were determined through the ELISA technique with the Human CXCL13/BLC/BCA-1 kit. CSF cell count, glucose and protein levels, along with anti-Borrelia burgdorferi antibodies were monitored using the ELISA technique. Results: CXCL13 chemokine levels in the CSF of patients with acute infectious neurological diseases showed a median value of 23.07 pg/mL, which was significantly higher in comparison with the median value of 11.5 pg/mL of patients with noninfectious neurological diseases (p-0.03). CXCL13 median plasma concentration in patients with infectious neurological diseases was 108.1 pg/mL, in comparison with the second patient category, 50.7 pg/ml (p-0.001). We observed a statistically significant association between CXCL13 concentrations, CSF cell count and proteins. The higher the CXCL13 chemokine level, the more increased the cell count was. Conclusions: CXCL13 levels in the CSF was significantly increased in patients with acute infectious neurological diseases compared with patients with non-infectious diseases. Moreover, CXCL13 chemokine concentration was significantly correlated with the number of cells and proteins in the CSF of patients suffering from neuroinfections.Keywords
This publication has 26 references indexed in Scilit:
- Cerebrospinal fluid CXCL13 is a prognostic marker for aseptic meningitisJournal of Neuroimmunology, 2014
- CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammationJournal of Neuroinflammation, 2014
- Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infectionBMC Neurology, 2013
- CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammationJournal of Neuroinflammation, 2012
- Lyme borreliosisThe Lancet, 2012
- Discriminating Lyme Neuroborreliosis from Other Neuroinflammatory Diseases by Levels of CXCL13 in Cerebrospinal FluidJournal of Clinical Microbiology, 2011
- A prospective study on the role of CXCL13 in Lyme neuroborreliosisNeurology, 2011
- EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosisEuropean Journal of Neurology, 2009
- Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitmentBrain, 2005
- Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitisJournal of Neuroimmunology, 2004